Sanofi joins acne vaccine alliance with UCSD
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur, the vaccines division of Sanofi, has entered an R&D collaboration with the University of California, San Diego (UC San Diego) on an immunological approach to acne prevention and treatment specifically targeting Propionibacterium acnes.